Activation of type I NKT cells in tumors therefore appears desirable, since they display direct cytotoxicity towards tumor cells and produce large amounts of IFN-γ to further activate other cytotoxic immune cells such as NK cells and CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.